Supernus Pharmaceuticals, Inc. (SUPN)
50.71
-0.15
(-0.29%)
USD |
NASDAQ |
Feb 23, 16:00
50.71
0.00 (0.00%)
After-Hours: 19:16
Supernus Pharmaceuticals Profit Margin (Quarterly) : -23.49% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | -2.24% |
| Catalyst Pharmaceuticals, Inc. | 35.57% |
| Oncotelic Therapeutics, Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 36.91% |
| Krystal Biotech, Inc. | 47.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.84% |
| Return on Assets | -1.37% |
| Return on Invested Capital | -1.78% |
| Gross Profit Margin (Quarterly) | 77.20% |
| Operating Margin (Quarterly) | -31.77% |
| Return on Net Operating Assets | -2.13% |